Overview

Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine

Status:
Completed
Trial end date:
2017-07-06
Target enrollment:
Participant gender:
Summary
The purpose of the study is to describe the association/correlation between change in patient-reported cognitive symptoms and work productivity in gainfully employed patients receiving vortioxetine for a Major Depressive Episode (MDE).
Phase:
Phase 4
Details
Lead Sponsor:
Lundbeck Canada Inc.
Treatments:
Vortioxetine